Pharmaceutical

Sobi gains FDA approval for Gamifant to treat HLH/MAS

The FDA has approved Sobi's Gamifant (emapalumab) to treat adults and children w...

Torrent Pharmaceuticals to acquire stake in JB Pharma f...

Torrent has signed definitive agreements to acquire stake in JB Pharma at an equ...

US trade tariffs and the potential impact on pharma sup...

As the pharma sector braces for sector-specific tariffs from President Trump, wh...

Vetter breaks ground on $285m US clinical manufacturing...

Vetter Pharma, has begun the construction of a new clinical manufacturing facili...

CKD anemia market expected to reach $5.3bn across the 7...

The chronic kidney disease (CKD) anemia market across the seven major markets (7...

FDA removes safety programme for CAR-T therapies to boo...

The agency stated that REMS requirements can be removed because safety and effec...

FDA approves Takeda’s Gammagard liquid ERC for primary ...

The FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [...

WHO accuses China of withholding Covid-19 genetic data

WHO director Dr Tedros Adhanom Ghebreyesus says all hypotheses are on the table,...

FDA approves label updates for BMS’ CAR T cell therapies

Bristol Myers Squibb has announced that the FDA has given approval to label upda...

AI in drug discovery: from hypothetical to reality

AI has been a buzzword in the pharmaceutical industry for almost a decade, with ...

Viatris gains China approval for Yupelri to treat COPD

Theravance Biopharma’s partner Viatris has received China's NMPA approval for Yu...

Novo Nordisk teams up with WeightWatchers in latest tel...

The collaboration comes after Novo Nordisk terminated a frosty Hims & Hers partn...

Why can’t the US figure out weight loss drug prices?

Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and ...

Navigating uncertainty: the future of vaccine oversight...

The evolving landscape of vaccine oversight makes it key to maintain public trus...

BioCity’s SC0062 gains NMPA breakthrough therapy design...

The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) a...

Innovation in Focus: Highlights from the Two-Day London...

The London Biotechnology Show 2025, held from 18 to 19 June, encompassed a range...